SERNIVO Drug Patent Profile
✉ Email this page to a colleague
When do Sernivo patents expire, and when can generic versions of Sernivo launch?
Sernivo is a drug marketed by Primus Pharms and is included in one NDA. There are seven patents protecting this drug and one Paragraph IV challenge.
This drug has seven patent family members in five countries.
The generic ingredient in SERNIVO is betamethasone dipropionate. There are sixty-six drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sernivo
A generic version of SERNIVO was approved as betamethasone dipropionate by FOUGERA PHARMS on June 26th, 1984.
Summary for SERNIVO
International Patents: | 7 |
US Patents: | 7 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 46 |
Patent Applications: | 5,840 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for SERNIVO |
Drug Sales Revenues: | Drug sales revenues for SERNIVO |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for SERNIVO |
What excipients (inactive ingredients) are in SERNIVO? | SERNIVO excipients list |
DailyMed Link: | SERNIVO at DailyMed |



Anatomical Therapeutic Chemical (ATC) Classes for SERNIVO
Paragraph IV (Patent) Challenges for SERNIVO
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
SERNIVO | Topical Spray | betamethasone dipropionate | 0.05% | 208079 | 1 | 2018-02-15 |
US Patents and Regulatory Information for SERNIVO
SERNIVO is protected by seven US patents.
Patents protecting SERNIVO
Topical formulations comprising a steroid
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF PLAQUE PSORIASIS
Topical formulations comprising a steroid
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF PLAQUE PSORIASIS
Topical formulations comprising a steroid
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF PLAQUE PSORIASIS
Topical formulations comprising a steroid
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF PLAQUE PSORIASIS
Topical formulations comprising a steroid
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF PLAQUE PSORIASIS
Topical formulations comprising a steroid
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF PLAQUE PSORIASIS
Topical formulations comprising a steroid
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF PLAQUE PSORIASIS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Primus Pharms | SERNIVO | betamethasone dipropionate | SPRAY;TOPICAL | 208079-001 | Feb 5, 2016 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
Primus Pharms | SERNIVO | betamethasone dipropionate | SPRAY;TOPICAL | 208079-001 | Feb 5, 2016 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
Primus Pharms | SERNIVO | betamethasone dipropionate | SPRAY;TOPICAL | 208079-001 | Feb 5, 2016 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
Primus Pharms | SERNIVO | betamethasone dipropionate | SPRAY;TOPICAL | 208079-001 | Feb 5, 2016 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for SERNIVO
See the table below for patents covering SERNIVO around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 3141246 | See Plans and Pricing | |
Denmark | 2473161 | See Plans and Pricing | |
Spain | 2637447 | See Plans and Pricing | |
Japan | 5833007 | See Plans and Pricing | |
>Country | >Patent Number | >Title | >Estimated Expiration |